KOL | David J RissmillerDepartment of Psychiatry at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine in Stratford, Cherry Hill, NJ 08002-2051, USA. rissmidj@umdnj.edu |
KOL Resume for David J Rissmiller
| Year | |
|---|---|
| 2007 | Department of Psychiatry at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine in Stratford, Cherry Hill, NJ 08002-2051, USA. |
Prominent publications by David J Rissmiller
Bupropion hydrochloride is currently available in three formulations: immediate-release, sustained-release, and extended-release (ER). Several published reports exist concerning bupropion's history of inducing seizures in both the immediate- and sustained-release formulations. Although the potential of the ER formulation for causing seizures is noted in the drug's prescribing information, there is no previously published report of bupropion ER inducing seizures. In the case reported, a ...
| Known for Bupropion Hydrochloride | Published Reports | Antidepressive Agents | Tonic Clonic | Year Woman |
Key People For Bupropion Hydrochloride
David J Rissmiller:Expert Impact
Concepts for whichDavid J Rissmillerhas direct influence:Bupropion hydrochloride, Agents generation, Tonic clonic, Generation bupropion, Epilepsy tonic.
David J Rissmiller:KOL impact
Concepts related to the work of other authors for whichfor which David J Rissmiller has influence:Tobacco smoking, Psychotropic medications, Convulsant liability, New metabolites, Seizure risk, Motor threshold, Bupropion treatment.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |